Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

5.2K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.2K
Papillary Dermis01:11

Papillary Dermis

5.4K
Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen...
5.4K
Reticular Dermis01:15

Reticular Dermis

4.4K
The papillary and reticular dermis are the two layers of the dermis. They are made of connective tissue with fibers of collagen extending from one to the other, making the border between the two somewhat indistinct. The dermal papillae extending into the epidermis belong to the papillary layer, whereas the dense collagen fiber bundles below belong to the reticular layer.
Reticular Layer
Underlying the papillary layer is the much thicker reticular layer, composed of dense, irregular connective...
4.4K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

203
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
203
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

504
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
504
Autoimmune Disorders01:29

Autoimmune Disorders

1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic Glucocorticoid Immunosuppression and Survival Among Immune Checkpoint Inhibitor Recipients.

JAMA network open·2026
Same author

Identification of a distinct circulating CCL chemokine signature in neuropathic pruritus.

Journal of the American Academy of Dermatology·2026
Same author

Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.

Dermatology and therapy·2026
Same author

Somatic mutations reveal hyperactive Notch signaling in prurigo nodularis.

JCI insight·2026
Same author

Targeting noncanonical TGF-beta signaling: inhibition effects on the human keloid fibroblast transcriptome.

Itch (Philadelphia, Pa.)·2026
Same author

Human dorsal root ganglion-based itch subcluster mapping and pathway analysis through single-nucleus RNA sequencing.

The Journal of investigative dermatology·2026
Same journal

Letter to the editor in reply to "Ethics of Rising Trends in Dermatology Publications Using Large-Scale Databases".

Clinics in dermatology·2026
Same journal

Ethics of suggesting image-guided superficial radiation therapy on the pathology report.

Clinics in dermatology·2026
Same journal

Tanorexia: The Psychodermatology of Compulsive Tanning.

Clinics in dermatology·2026
Same journal

Ear manifestations of connective tissue diseases: A dermatologic, histopathologic, and clinicopathologic review.

Clinics in dermatology·2026
Same journal

Discovery of an intravenous drug injection site: A meticulous cutaneous examination provides the forensic dermatologic clue to a diagnosis of homicide.

Clinics in dermatology·2026
Same journal

Sherlock Holmes and the mystery of the deadly diet.

Clinics in dermatology·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

570

Comorbidities in prurigo nodularis.

Jaya Manjunath1, Brenda Umenita Akinniyi1, Alexander L Kollhoff1

  • 1Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Clinics in Dermatology
|September 14, 2025
PubMed
Summary
This summary is machine-generated.

Prurigo nodularis (PN) is a chronic inflammatory skin condition causing intense itch and nodules. Its management requires addressing significant impacts on quality of life and numerous associated health conditions.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K

Related Experiment Videos

Last Updated: Jan 17, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

570
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.4K

Area of Science:

  • Dermatology
  • Immunology
  • Neurology

Background:

  • Prurigo nodularis (PN) is a chronic inflammatory skin disease defined by severe itch and hyperkeratotic nodules.
  • Its pathogenesis involves complex neuroimmune dysregulation with inflammatory cytokines and neuropeptides.
  • PN substantially diminishes patients' quality of life, more so than other chronic pruritic conditions.

Purpose of the Study:

  • To summarize the current understanding of Prurigo nodularis pathogenesis, clinical presentation, and management.
  • To highlight the significant impact of PN on patient quality of life.
  • To underscore the importance of identifying and managing comorbidities associated with PN.

Main Methods:

  • Review of existing literature on Prurigo nodularis.
  • Analysis of the role of neuroimmune pathways in PN.
  • Evaluation of systemic and psychiatric comorbidities linked to PN.
  • Assessment of current and emerging treatment strategies.

Main Results:

  • PN pathogenesis involves neuroimmune dysregulation and inflammatory mediators.
  • Patients with PN experience greater disease severity, itch intensity, and reduced quality of life.
  • PN is linked to numerous systemic comorbidities (e.g., CKD, cardiovascular disease, HIV) and psychiatric conditions (e.g., depression, anxiety).
  • Neurologic comorbidities like neuropathic pain and sleep disturbances are also prevalent.

Conclusions:

  • Comprehensive assessment for comorbidities is crucial for personalized PN management.
  • Treatment aims to alleviate itch and improve quality of life, utilizing immunosuppressants, neuromodulators, or biologics like dupilumab.
  • Further research into PN pathogenesis and targeted therapies is warranted.